Growth Metrics

Marimed (MRMD) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to -$2.9 million.

  • Marimed's Income towards Parent Company fell 19707.07% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 2541.25%. This contributed to the annual value of -$12.2 million for FY2024, which is 2398.33% up from last year.
  • According to the latest figures from Q3 2025, Marimed's Income towards Parent Company is -$2.9 million, which was down 19707.07% from -$1.3 million recorded in Q2 2025.
  • In the past 5 years, Marimed's Income towards Parent Company ranged from a high of $7.6 million in Q2 2021 and a low of -$10.1 million during Q4 2023
  • Over the past 5 years, Marimed's median Income towards Parent Company value was -$990000.0 (recorded in 2024), while the average stood at -$859842.1.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first soared by 76498.31% in 2021, then tumbled by 31950.46% in 2025.
  • Marimed's Income towards Parent Company (Quarter) stood at -$6.4 million in 2021, then surged by 174.13% to $4.7 million in 2022, then crashed by 313.5% to -$10.1 million in 2023, then rose by 21.08% to -$8.0 million in 2024, then skyrocketed by 63.25% to -$2.9 million in 2025.
  • Its Income towards Parent Company was -$2.9 million in Q3 2025, compared to -$1.3 million in Q2 2025 and -$5.4 million in Q1 2025.